423 related articles for article (PubMed ID: 36614146)
21. TRPM8 and Migraine.
Dussor G; Cao YQ
Headache; 2016 Oct; 56(9):1406-1417. PubMed ID: 27634619
[TBL] [Abstract][Full Text] [Related]
22. Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine.
Demartini C; Greco R; Magni G; Zanaboni AM; Riboldi B; Francavilla M; Nativi C; Ceruti S; Tassorelli C
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430567
[TBL] [Abstract][Full Text] [Related]
23. [Migraine: advances in the pathophysiology and treatment].
Shimizu T; Shibata M; Suzuki N
Rinsho Shinkeigaku; 2011 Feb; 51(2):103-9. PubMed ID: 21404609
[TBL] [Abstract][Full Text] [Related]
24. Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels.
Kleeberg-Hartmann J; Vogler B; Messlinger K
J Headache Pain; 2021 Apr; 22(1):23. PubMed ID: 33849430
[TBL] [Abstract][Full Text] [Related]
25. Thermo-Sensitive TRP Channels: Novel Targets for Treating Chemotherapy-Induced Peripheral Pain.
Nazıroğlu M; Braidy N
Front Physiol; 2017; 8():1040. PubMed ID: 29326595
[TBL] [Abstract][Full Text] [Related]
26. Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine.
Cohen CF; Roh J; Lee SH; Park CK; Berta T
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175602
[TBL] [Abstract][Full Text] [Related]
27. Modification of the TRP Channel TRPA1 as a Relevant Factor in Migraine-Related Intracranial Hypersensitivity.
Masood T; Lakatos S; Rosta J
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982450
[TBL] [Abstract][Full Text] [Related]
28. The role of chemosensitive afferent nerves and TRP ion channels in the pathomechanism of headaches.
Dux M; Sántha P; Jancsó G
Pflugers Arch; 2012 Sep; 464(3):239-48. PubMed ID: 22875278
[TBL] [Abstract][Full Text] [Related]
29. TRPA1/NOX in the soma of trigeminal ganglion neurons mediates migraine-related pain of glyceryl trinitrate in mice.
Marone IM; De Logu F; Nassini R; De Carvalho Goncalves M; Benemei S; Ferreira J; Jain P; Li Puma S; Bunnett NW; Geppetti P; Materazzi S
Brain; 2018 Aug; 141(8):2312-2328. PubMed ID: 29985973
[TBL] [Abstract][Full Text] [Related]
30. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
Sałat K; Filipek B
J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
[TBL] [Abstract][Full Text] [Related]
31. Transient receptor potential melastatin 8 is required for nitroglycerin- and calcitonin gene-related peptide-induced migraine-like pain behaviors in mice.
Wei C; Kim B; McKemy DD
Pain; 2022 Dec; 163(12):2380-2389. PubMed ID: 35353773
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine.
Greco R; Demartini C; Francavilla M; Zanaboni AM; Tassorelli C
Cells; 2022 Sep; 11(19):. PubMed ID: 36231054
[TBL] [Abstract][Full Text] [Related]
33. Emerging Perspectives on Pain Management by Modulation of TRP Channels and ANO1.
Takayama Y; Derouiche S; Maruyama K; Tominaga M
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336748
[TBL] [Abstract][Full Text] [Related]
34. Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel.
Materazzi S; Benemei S; Fusi C; Gualdani R; De Siena G; Vastani N; Andersson DA; Trevisan G; Moncelli MR; Wei X; Dussor G; Pollastro F; Patacchini R; Appendino G; Geppetti P; Nassini R
Pain; 2013 Dec; 154(12):2750-2758. PubMed ID: 23933184
[TBL] [Abstract][Full Text] [Related]
35. Role of transient receptor potential ankyrin 1 receptors in rodent models of meningeal nociception - Experiments in vitro.
Denner AC; Vogler B; Messlinger K; De Col R
Eur J Pain; 2017 May; 21(5):843-854. PubMed ID: 27977070
[TBL] [Abstract][Full Text] [Related]
36. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
Kopruszinski CM; Navratilova E; Swiokla J; Dodick DW; Chessell IP; Porreca F
Cephalalgia; 2021 Mar; 41(3):305-317. PubMed ID: 32985222
[TBL] [Abstract][Full Text] [Related]
37. TRP channels: potential drug target for neuropathic pain.
Marwaha L; Bansal Y; Singh R; Saroj P; Bhandari R; Kuhad A
Inflammopharmacology; 2016 Dec; 24(6):305-317. PubMed ID: 27757589
[TBL] [Abstract][Full Text] [Related]
38. Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model.
Demartini C; Greco R; Zanaboni AM; Francesconi O; Nativi C; Tassorelli C; Deseure K
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366396
[TBL] [Abstract][Full Text] [Related]
39. Targeting TRP channels for pain relief.
Brederson JD; Kym PR; Szallasi A
Eur J Pharmacol; 2013 Sep; 716(1-3):61-76. PubMed ID: 23500195
[TBL] [Abstract][Full Text] [Related]
40. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
Messlinger K; Fischer MJ; Lennerz JK
Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
